The control group:The placebo

5 trials

Sponsors

The Second Hospital Affiliated to Chongqing Medical University, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Changhai Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Changchun University of Chinese Medicine

Conditions

Chronic heart failureDiabetic NephropathyMetabolic diseasesNAFLDfunctional dyspepsia

Early Phase 1

Study for the influencing factors of adverse drug reaction of metformin and its correlation with gene polymorphism

RecruitingChiCTR1900023116

The Second Hospital Affiliated to Chongqing Medical UniversityMetabolic diseases

Start: 2019-05-11Updated: 2019-05-13

Phase 1

Shenan Tongluo decoction in treatment of diabetic kidney disease: Study protocol for a randomized Controlled trial

RecruitingITMCTR2100005191

Changchun University of Chinese MedicineDiabetic Nephropathy

Start: 2021-08-10Updated: 2023-02-20

Phase 4

A randomized, double-blind, placebo-controlled, parallel-controlled, superiority multicenter clinical study of Debitai in patients with functional dyspepsia

Active, not recruitingChiCTR2300068489

Shanghai Changhai Hospitalfunctional dyspepsia

Start: 2023-03-01Updated: 2023-05-22

Unknown Phase

Assessment for clinical curative effect of YangXinXue KeLi granule in the treatment of chronic heart failure

RecruitingChiCTR-INR-17010696

Affiliated Hospital of Chengdu University of Traditional Chinese MedicineChronic heart failure

Start: 2017-03-01Updated: 2017-04-18

Clinical effect evaluation of Lanzhang granules on spleen deficiency and Phlegm stasis syndrome of non-alcoholic fatty liver disease : a randomized, double-blind, placebo-controlled clinical trial

Active, not recruitingChiCTR2200061642

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese MedicineNAFLD

Start: 2022-06-16Updated: 2023-04-03